NANOVAE to Treat Knee Osteoarthritis (KOA)

NCT06606561 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: NANOVAE - Acellular Allogenic Human Amniotic Fluid (hAF)
DRUG: 0.9% Sodium Chloride Injection, USP

Sponsor

Nova Vita Laboratory